Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2023

Chung EY, Sartori G, Ponzoni M, Cascione L, Priebe V, Xu-Monette ZY, et al. ETS1 phosphorylation at threonine 38 is associated with the cell of origin of diffuse large B cell lymphoma and sustains the growth of tumour cells. Br J Haematol. 2023;203(2):244-254.

Camilleri AE, Cung M, Hart FM, Pagovich OE, Crystal RG, Greenblatt MB, et al. Gene Therapy to Treat Osteopenia Associated With Chronic Ethanol Consumption and Aldehyde Dehydrogenase 2 Deficiency. JBMR Plus. 2023;7(4):e10723.

Utsumi T, Yamada Y, Diaz-Meco MT, Moscat J, Nakanishi Y. Sessile serrated lesions with dysplasia: is it possible to nip them in the bud? J Gastroenterol. 2023;58(8):705-717.

Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IB, Berti E, et al. Correction: "The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms" Leukemia. 2022 Jul;36(7):1720-1748. Leukemia. 2023;37(9):1944-1951.

Stopsack KH, Su XA, J Vaselkiv B, Graff RE, Ebot EM, Pettersson A, et al. Transcriptomes of Prostate Cancer with TMPRSS2:ERG and Other ETS Fusions. Mol Cancer Res. 2023;21(1):14-23.

Mesa KR, O'Connor KA, Ng C, Salvatore SP, Littman DR. Niche-specific macrophage loss promotes skin capillary aging. bioRxiv. 2023.

Hao Y, Lynch K, Fan P, Jurtschenko C, Cid M, Zhao Z, et al. Development of a Machine Learning Algorithm for Drug Screening Analysis on High-Resolution UPLC-MSE/QTOF Mass Spectrometry. J Appl Lab Med. 2023;8(1):53-66.

Liu D, Cheng Y, Zhou H, Wang L, Fiel RH, Gruenstein Y, et al. Early Introduction and Community Transmission of SARS-CoV-2 Omicron Variant, New York, New York, USA. Emerg Infect Dis. 2023;29(2):371-380.

Santo EE, Ribel-Madsen R, Stroeken PJ, de Boer VC, Hansen NS, Commandeur M, et al. FOXO3A-short is a novel regulator of non-oxidative glucose metabolism associated with human longevity. Aging Cell. 2023;22(3):e13763.

Schreidah CM, Fahmy LM, Lapolla BA, Kwinta BD, Magro CM, Geskin LJ. Clinical Remission of Primary Cutaneous Marginal Zone B-Cell Lymphoma in a Patient With Crohn's Disease After Helicobacter pylori Quadruple Therapy and Vedolizumab. Am J Dermatopathol. 2023;45(8):572-576.